NO20051301L - Proteintyrosinforfataseinhibitorer - Google Patents

Proteintyrosinforfataseinhibitorer

Info

Publication number
NO20051301L
NO20051301L NO20051301A NO20051301A NO20051301L NO 20051301 L NO20051301 L NO 20051301L NO 20051301 A NO20051301 A NO 20051301A NO 20051301 A NO20051301 A NO 20051301A NO 20051301 L NO20051301 L NO 20051301L
Authority
NO
Norway
Prior art keywords
proteintyrosinforfataseinhibitorer
phosphopeptides
relates
present
medical applications
Prior art date
Application number
NO20051301A
Other languages
English (en)
Inventor
Rob Hooft Van Huijsduijnen
Sebastien Walchli
Fabrizio Arigoni
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems filed Critical Applied Research Systems
Publication of NO20051301L publication Critical patent/NO20051301L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/04—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
    • C07K1/047—Simultaneous synthesis of different peptide species; Peptide libraries
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Communicable Diseases (AREA)
  • Emergency Medicine (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

Den foreliggende oppfinnelsen angår fosfopeptider som inhiberer proteintyrosinfosfataser og deres medisinske anvendelser.
NO20051301A 2002-08-29 2005-03-14 Proteintyrosinforfataseinhibitorer NO20051301L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02019357 2002-08-29
PCT/EP2003/050385 WO2004020466A1 (en) 2002-08-29 2003-08-20 Protein tyrosine phosphatase inhibitors

Publications (1)

Publication Number Publication Date
NO20051301L true NO20051301L (no) 2005-03-14

Family

ID=31970273

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20051301A NO20051301L (no) 2002-08-29 2005-03-14 Proteintyrosinforfataseinhibitorer

Country Status (7)

Country Link
US (1) US20060241020A1 (no)
EP (1) EP1532171A1 (no)
JP (1) JP2006513143A (no)
AU (1) AU2003271748A1 (no)
CA (1) CA2496772A1 (no)
NO (1) NO20051301L (no)
WO (1) WO2004020466A1 (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7547760B2 (en) * 2006-07-03 2009-06-16 West Virginia University Peptides and chemical compound for inhibition of SHP2 function
WO2008124815A1 (en) * 2007-04-10 2008-10-16 University Of South Florida Method of activating nk cells
US9387644B1 (en) 2011-04-15 2016-07-12 Kennon Products, Inc. Ballistic resistant material with nonorthogonal stitching
WO2021096270A1 (ko) * 2019-11-14 2021-05-20 주식회사 진큐어 Ampk 억제기능과 아연항상성 조절기능에 기반한 다발성 경화증 치료용 약학적 조성물
CN112843027B (zh) * 2021-02-03 2022-08-09 中山大学 2-氯-6-甲氧基间苯二酚在抑制结核分枝杆菌酪氨酸磷酸酶a中的用途

Also Published As

Publication number Publication date
CA2496772A1 (en) 2004-03-11
AU2003271748A1 (en) 2004-03-19
EP1532171A1 (en) 2005-05-25
WO2004020466A1 (en) 2004-03-11
US20060241020A1 (en) 2006-10-26
WO2004020466A8 (en) 2005-01-20
JP2006513143A (ja) 2006-04-20

Similar Documents

Publication Publication Date Title
EA200701918A1 (ru) Белок липокалин
FR16C0028I2 (fr) Vecteurs viraux et utilisation de ces derniers dans des methodes therapeutiques
NO20041917D0 (no) Spesifikke midler som binder humant angiopoietin-2
YU9404A (sh) Multimerna, usmerena kontrastna sredstva na bazi peptida
DE60315846D1 (de) Zusammenbau von chirurgischem klammerwerkzeug
ATE433973T1 (de) Azolylaminoazine als inhibitoren von proteinkinasen
NO20055130L (no) Aminocykloheksyleter-forbindelser og deres anvendelse
ATE420879T1 (de) Indolizine als kinaseproteinhemmer
ECSP066411A (es) Tienopirazoles
GEP20104974B (en) Carbonylamino pyrrolopyrazoles, protent kinase inhibitors
ATE543907T1 (de) Stresstolerante baumwollpflanzen
SE0301653D0 (sv) Novel compounds
EA200701528A1 (ru) Новые нутрицевтические композиции
DK1668001T3 (da) Substituerede heteroarylbenzofuransyrer
HUP0402396A2 (hu) Aszkomicintartalmú, a szem kezelésére szolgáló készítmények
ATE330017T1 (de) Kallikrein gen
ATE363531T1 (de) Claudin polypeptide
DK1519944T3 (da) Fremgangsmåder til fremstilling af fibrinogen
ATE543833T1 (de) Bmp-7-varianten-zusammensetzungen, verfahren und verwendungen
EA200601743A1 (ru) Выделенный полипептид реналазы и его применение
NO20051301L (no) Proteintyrosinforfataseinhibitorer
DK1622939T3 (da) Aktive varianter af det IL-18-bindende protein og medicinske anvendelser deraf
NO20073071L (no) Benzotiazolformuleringer og anvendelse av disse
ATE410235T1 (de) Behandlung von ballastwasser
DE602004013557D1 (de) FLÜSSIGE FORMULIERUNGEN DES TUMORNEKROSEFRAKTOR-BINDUNGSPROTEINs TBP-1

Legal Events

Date Code Title Description
CREP Change of representative

Representative=s name: ONSAGERS AS, POSTBOKS 6963 ST OLAVS PLASS, 0130 OS

FC2A Withdrawal, rejection or dismissal of laid open patent application